Pharmacodynamics of mycophenolate mofetil after nonmyeloablative conditioning and unrelated donor hematopoietic cell transplantation

The immunosuppressive drug mycophenolate mofetil (MMF) is used after nonmyeloablative hematopoietic cell transplantation (HCT); however, limited pharmacodynamic data are available. We evaluated plasma concentrations of mycophenolic acid (MPA), the active metabolite of MMF, and outcomes in 85 patient...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Asıl Yazarlar: Giaccone, Luisa, McCune, Jeannine S., Maris, Michael B., Gooley, Theodore A., Sandmaier, Brenda M., Slattery, John T., Cole, Scott, Nash, Richard A., Storb, Rainer F., Georges, George E.
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: © 2005 by The American Society of Hematology 2005
Konular:
Transplantation
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC1895247/
https://ncbi.nlm.nih.gov/pubmed/16144801
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1182/blood-2005-06-2217
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller